About Transcell Oncologics Private Limited
Data last updated: 24 July 2025
Transcell Oncologics Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Tran-Scell Biologics Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. The company specialised in research and development. Incorporated on 02 August 2017.
Registered with ROC Hyderabad under CIN U74999TG2017PTC118680.
Capital: an authorised share capital of ₹1.5 Lakh and a paid-up capital of ₹1.29 Lakh. It was led by directors including Uday Chatterjee and Vinayender Tulla.
Last AGM: 30 September 2023. Financial statements filed for year ended 31 March 2023. Office: 8Th Floor Western Pearl Kondapur, Hyderabad, Telangana, India – 500084.
As per the financials filed for FY 2023, the company reported a revenue of ₹4.04 Cr, a growth of 3% compared to the previous year.
It operated as a subsidiary of Tran-Scell Biologics Private Limited.
The company was associated with 1 brand - Transcell Biolife. As per MCA filings, the company had satisfied charges of ₹27 Lakh on record.
The company has been merged (amalgamated) with another entity and no longer exists separately. Business activities, if any, continue under the successor entity. The last known website on record is transcellonco.science.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered Address8Th Floor Western Pearl Kondapur, Hyderabad, Telangana, India – 500084
-
IndustryResearch & Development, Research & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Transcell Oncologics Private Limited
Transcell Oncologics Private Limited operates one associated brand: Transcell Biolife. These brands represent Transcell Oncologics Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Developer of stem cell technologies to screen small molecules for solid tumors | transcellonco.science |
Competitors & Alternatives of Transcell Oncologics Private Limited
Brands and companies operating in the same space as Transcell Oncologics Private Limited include Hummingbird Bioscience, Lyell Immunopharma, GigaGen and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Hummingbird Bioscience
|
Antibody drugs for cancer treatment are developed. | Singapore, Singapore, Singapore | 2015 |
Lyell Immunopharma
|
CAR-T and TIL immunotherapies for solid tumors are developed. | San Francisco, United States, United States | 2018 |
GigaGen
|
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms. | San Francisco, United States, United States | 2011 |
Biocare Medical
|
Primary antibodies and instruments for immunohistochemistry are manufactured. | Concord, United States, United States | 1997 |
Merck
|
Merck is engaged in science and technology solutions globally. | Darmstadt, Germany, Germany | - |
TScan Therapeutics
|
T cell-based treatments for immunological and oncological disorders are developed. | Boston, United States, United States | 1995 |
Quanterix
|
Assay kits for ultra-sensitive biomarker detection are developed. | Cambridge, United States, United States | 2007 |
BioLife Solutions
|
Tissue hypothermic storage and cryopreservation freeze media are developed. | Bothell, United States, United States | 1987 |
Business Activity of Transcell Oncologics Private Limited
Transcell Oncologics Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details for Transcell Oncologics Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Transcell Oncologics Private Limited
Transcell Oncologics Private Limited is audited by KAVADAPU AND ASSOCIATES for the financial year 2021. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KAVADAPU AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history for Transcell Oncologics Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Transcell Oncologics Private Limited
Transcell Oncologics Private Limited is currently managed by 3 directors, with 1 former director having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Uday Chatterjee | Director | 05 Jul 2021 | 5 Years 0 Months | As last reported |
|
Vinayender Tulla
Also directs:
Tran-Scell Biologics Private Limited, Joy Retail & Technologies Private Limited, Vandanam Constructions Private Limited and 5 more
|
Director | 02 Aug 2017 | 8 Years 11 Months | As last reported |
| Subhadra Dravida | Director | 02 Aug 2017 | 8 Years 11 Months | As last reported |
Financials of Transcell Oncologics Private Limited FY 2023 filings available
Transcell Oncologics Private Limited reported revenue of ₹4.04 Cr (up 3.00% YoY) for FY 2023.
Ten-year financial statements for Transcell Oncologics Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Transcell Oncologics Private Limited
Shareholding and ownership data for Transcell Oncologics Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Transcell Oncologics Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jul 2021 | Hdfc Bank Limited | ₹27 Lakh | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Transcell Oncologics Private Limited
View historical data on people associated with Transcell Oncologics Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Transcell Oncologics Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Transcell Oncologics Private Limited
GST registrations and filing compliance for Transcell Oncologics Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Transcell Oncologics Private Limited
Credit ratings, litigation, and regulatory alerts for Transcell Oncologics Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Transcell Oncologics Private Limited
MSME payment history for Transcell Oncologics Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Transcell Oncologics Private Limited
Corporate group structure for Transcell Oncologics Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Transcell Oncologics Private Limited
MCA filings and documents for Transcell Oncologics Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Transcell Oncologics Private Limited
Frequently Asked Questions about Transcell Oncologics Private Limited
Transcell Oncologics Private Limited has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Transcell Oncologics Private Limited is a amalgamated private limited company in the research and development sector based in Hyderabad, Telangana, India. It was incorporated on 02 August 2017 and is registered under CIN U74999TG2017PTC118680. The company was amalgamated as per MCA records and no longer exists as a legal entity.
Transcell Oncologics Private Limited was incorporated on 02 August 2017. Registered with ROC Hyderabad.
The current directors of Transcell Oncologics Private Limited are:
- Uday Chatterjee - Director
- Vinayender Tulla - Director
- Subhadra Dravida - Director
The CIN (Corporate Identification Number) of Transcell Oncologics Private Limited is U74999TG2017PTC118680. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The primary industry of Transcell Oncologics Private Limited is research and development. The company specifically operates in research and development.